“RIVAROXABAN: AN ORAL DIRECT INHIBITOR OF FACTOR X-A”. International Research Journal of Pharmacy 2, no. 8 (November 25, 2024): 1–5. Accessed May 26, 2026. https://irjponline.org/index.php/irjp/article/view/1833.